Indian Laws Relevant to ADHD Care

This page summarises, in plain language, several Indian laws that come up in conversations about attention-deficit/hyperactivity disorder. It is general awareness material , not legal advice for any individual situation.

The Narcotic Drugs and Psychotropic Substances Act, 1985

The NDPS Act is the principal Indian statute regulating narcotic drugs and psychotropic substances. It was enacted to consolidate India's domestic obligations under the United Nations conventions on these substances. Methylphenidate , one of the medications used in the management of ADHD , is included in the schedule of psychotropic substances under the Act. It is also notified under Schedule X of the Drugs and Cosmetics Rules, 1945.

Schedule X classification means that pharmacies are required to maintain prescriptions in duplicate, retain records for a defined period, and follow specific format requirements when dispensing. These rules are part of the reason that retail availability of methylphenidate in India can be inconsistent, even where a valid prescription exists.

The Mental Healthcare Act, 2017

The Mental Healthcare Act, 2017 establishes a rights-based framework for persons with mental illness in India. Section 21(4) of the Act requires insurers to make provision for medical insurance for the treatment of mental illness on the same basis as physical illness. The Insurance Regulatory and Development Authority of India has subsequently issued circulars directing insurers to implement this parity requirement.

Whether and to what extent ADHD specifically is covered under a given insurance policy depends on the policy. The general direction of travel since 2017 has been towards inclusion; specifics vary across insurers.

The Rights of Persons with Disabilities Act, 2016

The Rights of Persons with Disabilities Act, 2016 lists "specific learning disabilities" among the recognised disabilities and establishes obligations relating to inclusive education, reasonable accommodations, and non-discrimination. The treatment of ADHD specifically continues to be the subject of interpretive guidelines and case law.

The Telemedicine Practice Guidelines, 2020

Issued under the Indian Medical Council Act framework, the Telemedicine Practice Guidelines, 2020 set out the conditions under which registered medical practitioners may consult patients remotely. The Guidelines categorise medicines into List O, List A, List B, and a prohibited list, with progressively stricter conditions on what may be prescribed by tele-consultation. Substances scheduled under the NDPS Act and Schedule X are subject to additional restrictions.

The Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 governs the processing of personal data in India. Consent, purpose limitation, and data minimisation principles apply. Processing of children's personal data attracts additional protections.

Drugs and Cosmetics Rules, 1945 , Schedules H, H1, and X

The Drugs and Cosmetics Rules, 1945 maintain several schedules that classify medicines by the level of regulatory control around their dispensation. Schedule H covers ordinary prescription medicines. Schedule H1 covers a more restrictive subset including specific antibiotics, anti-tuberculosis medicines, and certain psychotropics. Schedule X covers a smaller and more tightly regulated set, with duplicate prescription and record-retention obligations on pharmacies.

For your specific situation

The summaries above are general descriptions of the law as it stands at the time of publication. Application to a specific situation depends on facts that this page cannot address. For questions about your circumstances, please consult a lawyer.

Sources